Correlation Between GlaxoSmithKline PLC and Oppenheimer Steelpath

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Oppenheimer Steelpath at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Oppenheimer Steelpath into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Oppenheimer Steelpath Mlp, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Oppenheimer Steelpath and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Oppenheimer Steelpath. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Oppenheimer Steelpath.

Diversification Opportunities for GlaxoSmithKline PLC and Oppenheimer Steelpath

-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Oppenheimer is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Oppenheimer Steelpath Mlp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oppenheimer Steelpath Mlp and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Oppenheimer Steelpath. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oppenheimer Steelpath Mlp has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Oppenheimer Steelpath go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Oppenheimer Steelpath

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 6.11 times less return on investment than Oppenheimer Steelpath. In addition to that, GlaxoSmithKline PLC is 1.82 times more volatile than Oppenheimer Steelpath Mlp. It trades about 0.02 of its total potential returns per unit of risk. Oppenheimer Steelpath Mlp is currently generating about 0.17 per unit of volatility. If you would invest  637.00  in Oppenheimer Steelpath Mlp on August 31, 2024 and sell it today you would earn a total of  353.00  from holding Oppenheimer Steelpath Mlp or generate 55.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.73%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Oppenheimer Steelpath Mlp

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Oppenheimer Steelpath Mlp 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Oppenheimer Steelpath Mlp are ranked lower than 22 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Oppenheimer Steelpath showed solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and Oppenheimer Steelpath Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Oppenheimer Steelpath

The main advantage of trading using opposite GlaxoSmithKline PLC and Oppenheimer Steelpath positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Oppenheimer Steelpath can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oppenheimer Steelpath will offset losses from the drop in Oppenheimer Steelpath's long position.
The idea behind GlaxoSmithKline PLC ADR and Oppenheimer Steelpath Mlp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume